DOVATO

DRUG3 trials

Sponsors

ViiV Healthcare, Societa' Italiana Di Malattie Infettive E Tropicali, Saskatchewan Health Authority - Regina Area

Conditions

HIV InfectionsHIV-1-infectionOpioid Use Disorder

Phase 1

A Food-effect Study of the Pediatric Dispersible Tablet Formulations of TRIUMEQ® and DOVATO® in Healthy Adult Participants

CompletedNCT04827134

ViiV HealthcareHIV Infections

Start: 2021-05-07End: 2021-07-23Updated: 2023-06-05

Phase 3

Early DOlutegravir/LAmivudine Switching After Virological Suppression (EDOLAS Study)

Societa' Italiana Di Malattie Infettive E TropicaliHIV-1-infection

Start: 2021-03-23End: 2024-04-01Target: 440Updated: 2021-07-28

Phase 4

Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT)

Not yet recruitingNCT06580873

Saskatchewan Health Authority - Regina AreaHIV-1-infection, Opioid Use Disorder

Start: 2024-09-30End: 2027-10-31Target: 40Updated: 2024-08-30